Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12615000693527
Ethics application status
Approved
Date submitted
16/06/2015
Date registered
3/07/2015
Date last updated
24/05/2017
Type of registration
Prospectively registered

Titles & IDs
Public title
Preventing tooth decay in children in a remote community in Australia.
Scientific title
Effectiveness, cost-effectiveness and cost-benefit of a single annual professional intervention for the prevention of childhood dental caries in a remote rural Indigenous community.
Secondary ID [1] 286903 0
Nil
Universal Trial Number (UTN)
U1111-1171-1262
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Dental Caries 295317 0
Condition category
Condition code
Oral and Gastrointestinal 295586 295586 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Public Health 295667 295667 0 0
Epidemiology

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
The dental prevention model will essentially reduce the microbial load with the topical disinfectant, povidone iodine; inhibit biofilm adherence to susceptible sites by application of fissure sealants and reduce the susceptibility of the tooth to demineralisation by acids generated in the microbial biofilm by the application of a fluoride varnish.

Topical Treatment by PVP-Iodine in conjunction with Fluoride Varnish is simple. The iodine comes in a single application swab. The total treatment time is 3 to 4 minutes and costs less than 20 cents. Clinically the teeth are brushed to remove debris and disrupt the biofilm; then dried with gauze, and painted with 0.2 ml PVP-Iodine. After the iodine application, the teeth are dried again and coated with fluoride varnish at the same visit. Product Name: Povidone Iodine Pads and Swabsticks.

Fluoride varnishes are a liquid resin or synthetic base that contain a high concentration of fluoride and set quickly on contact with teeth, even in the presence of saliva. The fluoride varnish takes 3-5 minutes to apply. Fluoride ions in the material are released when the pH drops in response to acid production in the biofilm on the tooth surface and these become available to promote remineralisation of damaged tooth enamel in early carious lesions (white spots). The fluorhydroxyapatite formed over time during the remineralisation process in an initial caries lesion is more resistant to future demineralisation. Product Name: Colgate Durphat -  Varnish Single Dose 5% Sodium Fluoride (22,600 ppm).

Dental decay most often occurs on the occlusal pits and fissures of permanent molar teeth. A pit and fissure sealant is defined as a material [both glass-ionomer and resin-based materials are widely used] that is introduced into the occlusal pits and fissures of caries susceptible teeth. Fissues sealant applications take about 15-30 minutes to complete. Product Name: Conseal-Clear, Conseal-Light Grey, Conseal F (White).

These interventions will be administered by a dentist or oral/dental health therapist, at baseline, years 1 and 2 of the study. All participants will receive the identical preventive intervention.
Intervention code [1] 292088 0
Prevention
Intervention code [2] 292162 0
Treatment: Other
Comparator / control treatment
The expected caries increment will be modelled from the three oral health surveys conducted in this community (2004; 2012 and 2015) and compared with the actual caries increment from 2015-2016; 2016-2017 and 2015-2017. The mean caries increment will be compared between the expected (modelled) and actual findings, and adjusted for known risk factors for dental caries.
Control group
Uncontrolled

Outcomes
Primary outcome [1] 295297 0
The International Caries Detection and Assessment system (ICDAS-II) for clinical caries diagnosis will be used to record caries experience.
Timepoint [1] 295297 0
This will be measured at the beginning of the study (baseline) and then 12 and 24 months later.
Primary outcome [2] 295371 0
The International Caries Detection and Assessment system (ICDAS-II) for clinical caries diagnosis will be used to measure caries incidence and increment.
Timepoint [2] 295371 0
12 and 24 months after the baseline survey.
Secondary outcome [1] 315278 0
General Child Quality of Life, the social impact of oral disorders and Oral Health-Related Quality of Life (OHRQoL).
Timepoint [1] 315278 0
This will be measured at the beginning of the study (baseline) and then 12 and 24 months later.
Secondary outcome [2] 315442 0
The retention of the fissure sealants at the follow-up periods will be assessed, and recorded via a visual clinical examination when the International Caries Detection and Assessment system (ICDAS-II) for clinical caries diagnosis is carried out. The fissure sealant is recorded as intact, partially intact or missing.
Timepoint [2] 315442 0
12 and 24 months after the baseline survey.
Secondary outcome [3] 315443 0
The pH of the oral environment is recorded by placing a piece of litmus paper in the mouth. Oral hydration is then visually assessed by observing saliva pooling in the floor of the mouth, by noting its constituency [watery, frothy or sticky], and by blotting the inside of the lower lip and timing how long it takes for beads of saliva to form from the minor salivary glands there. Stimulated saliva is then collected by spitting/dribbling into a cup whilst chewing on a piece of paraffin wax for five minutes. The volume is recorded.

A few drops of saliva/whole mouth fluid are pipetted from this reservoir onto Saliva-check Buffer papers (GC America Inc) to record buffering capacity. Caries Risk Test (CRT) kits (Ivoclar Vivadent, Australia) are used to further assess salivary buffering and the nutrient agar from these kits flooded with saliva and incubated for 48 hours at 37C to determine counts of Mutans streptococci?, Lactobacilli and yeasts.
Timepoint [3] 315443 0
This will be measured at the beginning of the study (baseline) and then 12 and 24 months later.
Secondary outcome [4] 315444 0
Resources use and costs of providing the intervention will be recorded throughout the intervention period. Resource use and costs to participants to receive the intervention (e.g. time off work to bring the child to the clinic) will be recorded as well as any emergency treatment required between annual visits by the team.
Timepoint [4] 315444 0
In years 1, 2 and 3 of the project.

Eligibility
Key inclusion criteria
All children (approximately 600-650) attending the two primary and one secondary school campuses will be invited to participate in the intervention study.
Minimum age
4 Years
Maximum age
17 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
None

Study design
Purpose of the study
Prevention
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
All children (approximately 600-650) attending the two primary and one secondary school campuses will be invited to participate in the intervention study.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
All baseline socio-demographic characteristics will be described for the study participants using counts and frequencies. Baseline and follow-up caries experience and questionnaire related information will be reported. Dental caries increment (incidence) will be the main outcome measure used to determine the effectiveness of the preventive intervention. The expected caries increment will be modelled from the three oral health surveys conducted in this community (2004; 2012 and 2015) and compared with the actual caries increment from 2015-2016; 2016-2017 and 2015-2017. The mean caries increment will be compared between the expected (modelled) and actual findings, and adjusted for known risk factors for dental caries. The hypothesis will be that caries increment observed in the period of 2015 to 2017 is smaller than the modelled caries increments. Two independent samples t-test will be used for the analysis with significance being determined if p<0.05. The entire study population will be invited to participate and therefore no sample size calculation was determined.

Children who receive only a part of the intervention will be separately assessed: for example we will have children who fully participate, those with baseline and only a year 1 follow-up, those with baseline and only a year 2 follow-up. This will ‘naturally’ further inform us on the most appropriate frequency of this preventive strategy. Both a group and matched analysis will be conducted to account for children who receive only part of the intervention.

Development of Markov Model
A health state transition Markov model will be developed using Tree Age pro software (TreeAge Software Inc., Williamstown, Massachusetts, USA) to analyse the cost effectiveness of the intervention. The model will be populated with the caries experience of the children in NPA using the intervention caries data and compared with modelled data from baseline in a non-intervention scenario. The model cohort will start at the age of 6 years where mixed dentition is emerging. The model will track these children up to 17 years using the data from the study for each year. Health states for the model will include “healthy” and “caries” health states. It is anticipated to have health states for conditions such as pulpal abscess as well. The model will be made sensitive for waiting periods, available treatment facilities, availability and costs of resident or fly-in/fly-out professional staff and common practices of the local dental clinics.


Costs calculations
The costs of providing the preventive intervention, the costs of all treatment for carious lesions, and the out-of-pocket costs in relation to caries experience will be assessed. These costs will be assigned to each child taking into account the number of surfaces treated. Cost intervention will include sealants, an oral anti-septic application, application of a fluoride varnish and including cost for human resources and logistics. The costs of treating incremental caries will be estimated using government costs for treatments. Total out-of-pocket costs for parents of children with caries will be calculated based on the quantities of resource use provided in the surveys. Mean, median and interquartile range costs will be presented for each major treatment category in caries. All costs will be presented in 2015 AUD.

Estimation of Utility weights
The utility values for dental health states will be estimated from the CHU-9D data. Using the CHU-9D (Child Health Utility) multi attribute utility instrument, quality of life scores (utility scores) for each caries severity level experienced by the children will be determined. A scoring algorithm that has been validated in the UK for CHU-9D for children will be applied. Utility scores will be presented for different age groups and gender. These values will contribute to estimate Quality Adjusted Life Years (QALYs). The CHU-9D will be validated in a similar Indigenous population prior to the application in the study population.

Transition probabilities
Caries increment prior to intervention and post intervention will be used to calculate transition probabilities respectively for the two scenarios of non-intervention and intervention examined by the Markov model. The caries increment rates for intervention will be directly observed. These rates for the non-intervention will be estimated from the modelled data.


Cost utility analysis
The cost utility of the “Big Bang” prevention strategy will be estimated using the Markov model. This analysis will adhere to the best modelling practices as given by ISPOR guidelines. All costs will be presented in 2015 AUD. Costs and outcomes will be discounted at 5% per year. The model will present the societal perspective. Incremental cost effectiveness ratio (ICER) will be generated by calculating incremental costs for caries treatment divided by the outcome (number of carious lesions prevented and QALYs gained separately). The intervention group will be compared with the modelled values for a non-intervention scenario. To address the uncertainty in the costs and effectiveness estimates, univariate sensitivity analyses will be used. For all probabilities, the 95% confidence intervals will be used, and for costs high and low values will be estimated. A probabilistic sensitivity analysis will also be performed by re-sampling 1000 times at random from the probability distributions for each parameter. This procedure is similar to multivariate sensitivity analysis and will address the uncertainty of all estimates simultaneously. Gamma distributions will be used for cost estimates and beta distributions will be used for probabilities.

Recruitment
Recruitment status
Active, not recruiting
Date of first participant enrolment
Anticipated
10/08/2015
Actual
1/08/2015
Date of last participant enrolment
Anticipated
30/11/2015
Actual
30/11/2015
Date of last data collection
Anticipated
10/10/2017
Actual
Sample size
Target
600
Accrual to date
Final
434
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 291459 0
Government body
Name [1] 291459 0
National Health and Medical Research Council
Country [1] 291459 0
Australia
Primary sponsor type
University
Name
Griffith University
Address
Gold Coast campus
GRIFFITH UNIVERSITY QLD 4222
Country
Australia
Secondary sponsor category [1] 290139 0
None
Name [1] 290139 0
Address [1] 290139 0
Country [1] 290139 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 293008 0
Griffith University Human Ethics Committee
Ethics committee address [1] 293008 0
Ethics committee country [1] 293008 0
Australia
Date submitted for ethics approval [1] 293008 0
Approval date [1] 293008 0
14/04/2015
Ethics approval number [1] 293008 0
DOH/05/15/HREC
Ethics committee name [2] 293009 0
Far North Queensland Humans Research Ethics Committee
Ethics committee address [2] 293009 0
Ethics committee country [2] 293009 0
Australia
Date submitted for ethics approval [2] 293009 0
Approval date [2] 293009 0
01/06/2015
Ethics approval number [2] 293009 0
HREC/15/QCH/39 - 970

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 58058 0
Prof Newell W Johnson
Address 58058 0
Building G40, Room 9.16, Gold Coast Campus, Griffith University, Queensland 4222
Country 58058 0
Australia
Phone 58058 0
61, 07, 56789306
Fax 58058 0
Email 58058 0
[email protected]
Contact person for public queries
Name 58059 0
Newell W Johnson
Address 58059 0
Building G40, Room 9.16, Gold Coast Campus, Griffith University, Queensland 4222
Country 58059 0
Australia
Phone 58059 0
61, 07, 56789306
Fax 58059 0
Email 58059 0
[email protected]
Contact person for scientific queries
Name 58060 0
Newell W Johnson
Address 58060 0
Building G40, Room 9.16, Gold Coast Campus, Griffith University, Queensland 4222
Country 58060 0
Australia
Phone 58060 0
61, 07, 56789306
Fax 58060 0
Email 58060 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseEffectiveness, cost-effectiveness and cost-benefit of a single annual professional intervention for the prevention of childhood dental caries in a remote rural Indigenous community.2015https://dx.doi.org/10.1186/s12903-015-0076-9
EmbaseSalivary characteristics and dental caries experience in remote Indigenous children in Australia: a cross-sectional study.2019https://dx.doi.org/10.1186/s12903-018-0692-2
EmbaseResponse of Salivary Microbiota to Caries Preventive Treatment in Aboriginal and Torres Strait Islander Children.2020https://dx.doi.org/10.1080/20002297.2020.1830623
EmbaseSurface-specific caries preventive effect of an intervention comprising fissure sealant, povidone-iodine and fluoride varnish in a remote indigenous community in australia.2020https://dx.doi.org/10.3390/ijerph17062114
EmbaseCarious lesions in permanent dentitions are reduced in remote Indigenous Australian children taking part in a non-randomised preventive trial.2021https://dx.doi.org/10.1371/journal.pone.0244927
EmbasePredicting dental caries increment using salivary biomarkers in a remote Indigenous Australian child population.2021https://dx.doi.org/10.1186/s12903-021-01702-0
N.B. These documents automatically identified may not have been verified by the study sponsor.